4
Changes in Ownership
NEKTAR THERAPEUTICS Filed Acc 0001209191-20-019011
Director sold 8,000 shares at an average $16.79 ($134,316)
- Director acquired 8,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CHESS ROBERT Director | 2020-03-11 | Option exercise | −8,000 | $9.24 | $73,920 | 284,973 | D: show line 1 in the form |
| CHESS ROBERT Director | 2020-03-11 | Sale | −6,800 | $16.68 | $113,424 | 278,173 | D: show line 2 in the form |
| CHESS ROBERT Director | 2020-03-11 | Sale | −1,200 | $17.41 | $20,892 | 276,973 | D: show line 3 in the form |
| Open-market sales · 8,000 sh · avg $16.79 · $134,316 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| CHESS ROBERT Director | 2020-03-11 | Option exercise · Stock Option | −8,000 | 24,000 | D: show line 4 in the form |
Loading xslF345X03/doc4.xml…